Risk factors for noma disease: A 6-year, prospective, matched case-control study in Niger

The Lancet Global Health

Volumn 1, Issue 2, 2013, Pages

  Baratti Mayer, Denise ^a   Gayet Ageron, Angèle ^a   Hugonnet, Stéphane ^a,c   François, Patrice ^a   Pittet Cuenod, Brigitte ^a   Huyghe, Antoine ^a,b   Bornand, Jacques Etienne ^a   Gervaix, Alain ^a   Montandon, Denys ^a   Schrenzel, Jacques ^a   Mombelli, Andrea ^a,d   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METRONIDAZOLE; ALPHA TOCOPHEROL; RETINOL; RNA 16S;

ARTICLE; BIOTINYLATION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPECTROPHOTOMETRY; STOMATITIS; STRUCTURED INTERVIEW; BIRTH ORDER; BLOOD; CAPNOCYTOPHAGA; DIARRHEA; FAMILY SIZE; FEVER; FUSOBACTERIUM; GENETICS; GROWTH DISORDERS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MOUTH; NEISSERIA; NIGER; NOMA; POVERTY; PREVOTELLA; RESPIRATORY TRACT DISEASES; SPIROCHAETA; STATISTICS AND NUMERICAL DATA; WASTING SYNDROME;

ALPHA-TOCOPHEROL; BIRTH ORDER; CAPNOCYTOPHAGA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIARRHEA; FAMILY CHARACTERISTICS; FEMALE; FEVER; FUSOBACTERIUM; GROWTH DISORDERS; HUMANS; INFANT; MALE; MICROBIOTA; MOUTH; NEISSERIA; NIGER; NOMA; POVERTY; PREVOTELLA; PROSPECTIVE STUDIES; RESPIRATORY TRACT DISEASES; RISK FACTORS; RNA, RIBOSOMAL, 16S; SPIROCHAETA; VITAMIN A; WASTING SYNDROME;

EID: 84887570251     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70015-9     Document Type: Article

References (39)

1. Baratti-Mayer D, Pittet B, Montandon D, et al. Noma: an "infectious" disease of unknown aetiology. Lancet Infect Dis 2003, 3:419-431.
2. Oeuvres complètes d'Hippocrate 1849, Société Encyclographique des Sciences Médicales, Brussels. E. Littré (Ed.).
3. Adelsberger L Medical observations in Auschwitz concentration camp. Lancet 1946, 247:317-319.
4. Tempest MN Cancrum oris. Br J Surg 1966, 53:949-969.
5. Akula SK, Creticos CM, Weldon-Linne CM Gangrenous stomatitis in AIDS. Lancet 1989, 333:955.
6. Giovannini M, Zuccotti GV, Fiocchi A Gangrenous stomatitis in a child with AIDS. Lancet 1989, 334:1400.
7. Limongelli WA, Clark MS, Williams AC Noma-like lesion in a patient with chronic lymphocytic leukemia. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol 1976, 41:40-51.
8. Stassen LF, Batchelor AG, Rennie JS, Moos KF Cancrum oris in an adult Caucasian female. Br J Oral Maxillofac Surg 1989, 27:417-422.
9. Barmes DE, Enwonwu CO, Leclercq MH, Bourgeois D, Falkler WA The need for action against oro-facial gangrene (noma). Trop Med Int Health 1997, 2:1111-1114.
10. Bourgeois DM, Diallo B, Frieh C, Leclercq MH Epidemiology of the incidence of oro-facial noma: a study of cases in Dakar, Senegal, 1981-1993. Am J Trop Med Hyg 1999, 61:909-913.
11. Enwonwu CO, Falkler WA, Phillips RS Noma (cancrum oris). Lancet 2006, 368:147-156.
12. Enwonwu CO, Falkler WA, Idigbe EO, et al. Pathogenesis of cancrum oris (noma): confounding interactions of malnutrition with infection. Am J Trop Med Hyg 1999, 60:223-232.
13. Enwonwu CO, Phillips RS, Ferrell CD Temporal relationship between the occurrence of fresh noma and the timing of linear growth retardation in Nigerian children. Trop Med Int Health 2005, 10:65-73.
14. Montandon D, Lehmann C, Chami N The surgical treatment of noma. Plast Reconstr Surg 1991, 87:76-86.
15. WHO Working Group. Bull World Health Organ 1986, 64:929-941. Use and interpretation of anthropometric indicators of nutritional status.
16. Conley BA, Egorin MJ, Sridhara R, et al. Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics. Cancer Chemother Pharmacol 1997, 39:291-299.
17. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 199; 173: 697-703.
18. Bolivar I, Whiteson K, Stadelmann B, et al. Bacterial diversity in oral samples of children in Niger with acute noma, acute necrotizing gingivitis, and healthy controls. PLoS Negl Trop Dis 2012, 6:e1556.
19. Dupont WD Power calculations for matched case-control studies. Biometrics 1988, 44:1157-1168.
20. Benjamini Y, Hochberg Y Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Methodol 1995, 57:289-300.
21. Courvoisier DS, Combescure C, Agoritsas T, Gayet-Ageron A, Perneger TV Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure. J Clin Epidemiol 2011, 64:993-1000.
22. Huyghe A, Francois P, Charbonnier Y, et al. Novel microarray design strategy to study complex bacterial communities. Appl Environ Microbiol 2008, 74:1876-1885.
23. Enwonwu CO, Phillips RS, Savage KO Inflammatory cytokine profile and circulating cortisol levels in malnourished children with necrotizing ulcerative gingivitis. Eur Cytokine Netw 2005, 16:240-248.
24. Enwonwu CO Epidemiological and biochemical studies of necrotizing ulcerative gingivitis and noma (cancrum oris) in Nigerian children. Arch Oral Biol 1972, 17:1357-1371.
25. Enwonwu CO, Phillips RS, Ibrahim CD, Danfillo IS Nutrition and oral health in Africa. Int Dent J 2004, 54(suppl 1):344-351.
26. Lartey A Maternal and child nutrition in Sub-Saharan Africa: challenges and interventions. Proc Nutr Soc 2008, 67:105-108.
27. Contreras A, Falkler WA, Enwonwu CO, et al. Human Herpesviridae in acute necrotizing ulcerative gingivitis in children in Nigeria. Oral Microbiol Immunol 1997, 12:259-265.
28. Enwonwu CO, Falkler WA, Idigbe EO Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms. Crit Rev Oral Biol Med 2000, 11:159-171.
29. Eckstein A Noma. Am J Dis Children 1940, 59:219-237.
30. Emslie RD Cancrum oris. Dent Pract Dent Rec 1963, 13:481-495.
31. Paster BJ, Falkler WA, Enwonwu CO, et al. Prevalent bacterial species and novel phylotypes in advanced noma lesions. J Clin Microbiol 2002, 40:2187-2191.
32. Falkler WA, Enwonwu CO, Idigbe EO Isolation of Fusobacterium necrophorum from cancrum oris (noma). Am J Trop Med Hyg 1999, 60:150-156.
33. Enwonwu CO, Falkler WA, Idigbe EO, Savage KO Noma (cancrum oris): questions and answers. Oral Dis 1999, 5:144-149.
34. Slots J Bacterial specificity in adult periodontitis. A summary of recent work. J Clin Periodontol 1986, 13:912-917.
35. Frandsen EV, Reinholdt J, Kjeldsen M, Kilian M In vivo cleavage of immunoglobulin A1 by immunoglobulin A1 proteases from Prevotella and Capnocytophaga species. Oral Microbiol Immunol 1995, 10:291-296.
36. Brook I Recovery of anaerobic bacteria from four children with postthoracotomy sternal wound infection. Pediatrics 2001, 108:E17.
37. Rautio M, Saxen H, Siitonen A, Nikku R, Jousimies-Somer H Bacteriology of histopathologically defined appendicitis in children. Pediatr Infect Dis J 2000, 19:1078-1083.
38. Ximenez-Fyvie LA, Haffajee AD, Socransky SS Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis. J Clin Periodontol 2000, 27:722-732.
39. Amouzou A, Habi O, Bensaïd K Reduction in child mortality in Niger: a Countdown to 2015 country case study. Lancet 2012, 380:1169-1178.